Difference between revisions of "Main Page"
Jump to navigation
Jump to search
Mobile/tablet version of the main page
Browse our complete index of pages
m |
m (Added color to cells) |
||
| Line 9: | Line 9: | ||
<center><big>'''[[Main Page Mobile| Mobile/tablet version of the main page]]<br>[[Special:AllPages|Browse our complete index of pages]]'''</big></center> | <center><big>'''[[Main Page Mobile| Mobile/tablet version of the main page]]<br>[[Special:AllPages|Browse our complete index of pages]]'''</big></center> | ||
{| border="1" style="text-align:center;" | {| border="1" style="text-align:center;" | ||
| − | !colspan="4" align="center" style="background-color:# | + | !colspan="4" align="center" style="color:white; background-color:#800080"| Quick links to chemotherapy regimens |
|- | |- | ||
| − | + | !colspan="4" align="center" style="color:white; background-color:#00008B"| '''Solid tumors''' | |
|- | |- | ||
| − | |[[Anal cancer]] | + | |style="background-color:#7FFFD4"|[[Anal cancer]] |
| − | |[[Bladder cancer]] | + | |style="background-color:#7FFFD4"|[[Bladder cancer]] |
| − | |[[Bone cancer]] | + | |style="background-color:#7FFFD4"|[[Bone cancer]] |
| − | |[[Breast cancer]] | + | |style="background-color:#7FFFD4"|[[Breast cancer]] |
|- | |- | ||
| − | |[[Central nervous system (CNS) cancer]] | + | |style="background-color:#7FFFD4"|[[Central nervous system (CNS) cancer]] |
| − | |[[Cervical cancer]] | + | |style="background-color:#7FFFD4"|[[Cervical cancer]] |
| − | |[[Colon cancer]] | + | |style="background-color:#7FFFD4"|[[Colon cancer]] |
| − | |[[Esophageal cancer]] | + | |style="background-color:#7FFFD4"|[[Esophageal cancer]] |
|- | |- | ||
| − | |[[Gastric cancer]] | + | |style="background-color:#7FFFD4"|[[Gastric cancer]] |
| − | |[[Germ cell tumors]] | + | |style="background-color:#7FFFD4"|[[Germ cell tumors]] |
| − | |[[Head and neck cancer]] | + | |style="background-color:#7FFFD4"|[[Head and neck cancer]] |
| − | |[[Hepatobiliary cancer]] | + | |style="background-color:#7FFFD4"|[[Hepatobiliary cancer]] |
|- | |- | ||
| − | |[[Non-small cell lung cancer | Lung cancer, non-small cell]] | + | |style="background-color:#7FFFD4"|[[Non-small cell lung cancer | Lung cancer, non-small cell]] |
| − | |[[Small cell lung cancer | Lung cancer, small cell]] | + | |style="background-color:#7FFFD4"|[[Small cell lung cancer | Lung cancer, small cell]] |
| − | |[[Melanoma]] | + | |style="background-color:#7FFFD4"|[[Melanoma]] |
| − | |[[Mesothelioma]] | + | |style="background-color:#7FFFD4"|[[Mesothelioma]] |
|- | |- | ||
| − | |[[Neuroendocrine tumors]] | + | |style="background-color:#7FFFD4"|[[Neuroendocrine tumors]] |
| − | |[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]] | + | |style="background-color:#7FFFD4"|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]] |
| − | |[[Ovarian cancer]] | + | |style="background-color:#7FFFD4"|[[Ovarian cancer]] |
| − | |[[Pancreatic cancer]] | + | |style="background-color:#7FFFD4"|[[Pancreatic cancer]] |
|- | |- | ||
| − | |[[Penile cancer]] | + | |style="background-color:#7FFFD4"|[[Penile cancer]] |
| − | |[[Prostate cancer]] | + | |style="background-color:#7FFFD4"|[[Prostate cancer]] |
| − | |[[Rectal cancer]] | + | |style="background-color:#7FFFD4"|[[Rectal cancer]] |
| − | |[[Renal cancer]] | + | |style="background-color:#7FFFD4"|[[Renal cancer]] |
|- | |- | ||
| − | |[[Sarcoma]] | + | |style="background-color:#7FFFD4"|[[Sarcoma]] |
| − | |[[Testicular cancer]] | + | |style="background-color:#7FFFD4"|[[Testicular cancer]] |
| − | |[[Thymoma]] | + | |style="background-color:#7FFFD4"|[[Thymoma]] |
| − | |[[Thyroid cancer]] | + | |style="background-color:#7FFFD4"|[[Thyroid cancer]] |
|- | |- | ||
| − | |[[Unknown primary]] | + | |style="background-color:#7FFFD4"|[[Unknown primary]] |
| − | |[[Uterine cancer]] | + | |style="background-color:#7FFFD4"|[[Uterine cancer]] |
|- | |- | ||
| − | |colspan="4" align="center" style="background-color:#FF0D00"| '''Acute leukemias''' | + | |colspan="4" align="center" style="color:white; background-color:#FF0D00"| '''Acute leukemias''' |
|- | |- | ||
| − | |[[Acute lymphocytic leukemia | Acute lymphocytic leukemia (ALL)]] | + | |style="background-color:#FFC0CB"|[[Acute lymphocytic leukemia | Acute lymphocytic leukemia (ALL)]] |
| − | |[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] | + | |style="background-color:#FFC0CB"|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] |
| − | |[[Acute promyelocytic leukemia | Acute promyelocytic leukemia (APL)]] | + | |style="background-color:#FFC0CB"|[[Acute promyelocytic leukemia | Acute promyelocytic leukemia (APL)]] |
| − | |[[Transplant conditioning regimens]] | + | |style="background-color:#FFC0CB"|[[Transplant conditioning regimens]] |
|- | |- | ||
| − | |colspan="4" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes''' | + | |colspan="4" align="center" style="color:white; background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes''' |
|- | |- | ||
| − | |[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] | + | |style="background-color:#FFC0CB"|[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] |
| − | |[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]] | + | |style="background-color:#FFC0CB"|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]] |
| − | |[[Essential thrombocythemia | Essential thrombocythemia (ET)]] | + | |style="background-color:#FFC0CB"|[[Essential thrombocythemia | Essential thrombocythemia (ET)]] |
| − | |[[Hypereosinophilic syndrome (HES)]] | + | |style="background-color:#FFC0CB"|[[Hypereosinophilic syndrome (HES)]] |
|- | |- | ||
| − | |[[Mast cell diseases]] | + | |style="background-color:#FFC0CB"|[[Mast cell diseases]] |
| − | |[[Myelodysplastic syndrome]] | + | |style="background-color:#FFC0CB"|[[Myelodysplastic syndrome]] |
| − | |[[Myelofibrosis | Primary & secondary myelofibrosis]] | + | |style="background-color:#FFC0CB"|[[Myelofibrosis | Primary & secondary myelofibrosis]] |
| − | |[[Polycythemia vera | Polycythemia vera (PV)]] | + | |style="background-color:#FFC0CB"|[[Polycythemia vera | Polycythemia vera (PV)]] |
|- | |- | ||
| − | |colspan="4" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' | + | |colspan="4" align="center" style="color:white; background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' |
|- | |- | ||
| − | |[[Anaplastic large cell lymphoma|Anaplastic large cell lymphoma (ALCL)]] | + | |style="background-color:#FFC0CB"|[[Anaplastic large cell lymphoma|Anaplastic large cell lymphoma (ALCL)]] |
| − | |[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]] | + | |style="background-color:#FFC0CB"|[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]] |
| − | |[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) | Chronic lymphocytic leukemia (CLL/SLL)]] | + | |style="background-color:#FFC0CB"|[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) | Chronic lymphocytic leukemia (CLL/SLL)]] |
| − | |[[CNS lymphoma]] | + | |style="background-color:#FFC0CB"|[[CNS lymphoma]] |
|- | |- | ||
| − | |[[Cutaneous T-cell lymphoma|Cutaneous T-cell lymphoma (CTCL)]] | + | |style="background-color:#FFC0CB"|[[Cutaneous T-cell lymphoma|Cutaneous T-cell lymphoma (CTCL)]] |
| − | |[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]] | + | |style="background-color:#FFC0CB"|[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]] |
| − | |[[Extranodal NK/T-cell lymphoma, nasal type]] | + | |style="background-color:#FFC0CB"|[[Extranodal NK/T-cell lymphoma, nasal type]] |
| − | |[[Follicular lymphoma|Follicular lymphoma (FL)]] | + | |style="background-color:#FFC0CB"|[[Follicular lymphoma|Follicular lymphoma (FL)]] |
|- | |- | ||
| − | |[[Hairy cell leukemia|Hairy cell leukemia (HCL)]] | + | |style="background-color:#FFC0CB"|[[Hairy cell leukemia|Hairy cell leukemia (HCL)]] |
| − | |[[HIV-associated lymphoma]] | + | |style="background-color:#FFC0CB"|[[HIV-associated lymphoma]] |
| − | |[[Hodgkin lymphoma|Hodgkin lymphoma (HL)]] | + | |style="background-color:#FFC0CB"|[[Hodgkin lymphoma|Hodgkin lymphoma (HL)]] |
| − | |[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]] | + | |style="background-color:#FFC0CB"|[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]] |
|- | |- | ||
| − | |[[Large granular lymphocytic leukemia|Large granular lymphocytic (LGL) leukemia]] | + | |style="background-color:#FFC0CB"|[[Large granular lymphocytic leukemia|Large granular lymphocytic (LGL) leukemia]] |
| − | |[[Light-chain (AL) amyloidosis]] | + | |style="background-color:#FFC0CB"|[[Light-chain (AL) amyloidosis]] |
| − | |[[Mantle cell lymphoma|Mantle cell lymphoma (MCL)]] | + | |style="background-color:#FFC0CB"|[[Mantle cell lymphoma|Mantle cell lymphoma (MCL)]] |
| − | |[[Marginal zone lymphoma|Marginal zone lymphoma (MZL)]] | + | |style="background-color:#FFC0CB"|[[Marginal zone lymphoma|Marginal zone lymphoma (MZL)]] |
|- | |- | ||
| − | |[[Mediastinal gray-zone lymphoma|Mediastinal gray-zone lymphoma (MGZL)]] | + | |style="background-color:#FFC0CB"|[[Mediastinal gray-zone lymphoma|Mediastinal gray-zone lymphoma (MGZL)]] |
| − | |[[Multiple myeloma|Multiple myeloma (MM)]] | + | |style="background-color:#FFC0CB"|[[Multiple myeloma|Multiple myeloma (MM)]] |
| − | |[[NK/T-cell lymphoma]] | + | |style="background-color:#FFC0CB"|[[NK/T-cell lymphoma]] |
| − | |[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]] | + | |style="background-color:#FFC0CB"|[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]] |
|- | |- | ||
| − | |[[Primary mediastinal B-cell lymphoma|Primary mediastinal B-cell lymphoma (PMBL)]] | + | |style="background-color:#FFC0CB"|[[Primary mediastinal B-cell lymphoma|Primary mediastinal B-cell lymphoma (PMBL)]] |
| − | |[[Transformed lymphoma|Transformed lymphoma (TL)]] | + | |style="background-color:#FFC0CB"|[[Transformed lymphoma|Transformed lymphoma (TL)]] |
| − | |[[Transplant conditioning regimens]] | + | |style="background-color:#FFC0CB"|[[Transplant conditioning regimens]] |
| − | |[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM/LPL)]] | + | |style="background-color:#FFC0CB"|[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM/LPL)]] |
|- | |- | ||
| − | |colspan="4" align="center" style="background-color:# | + | |colspan="4" align="center" style="color:white; background-color:#228B22"| '''Other hematology''' |
|- | |- | ||
| − | |[[Aplastic anemia]] | + | |style="background-color:#98FB98"|[[Aplastic anemia]] |
| − | |[[Autoimmune thrombocytopenic purpura (ITP)]] | + | |style="background-color:#98FB98"|[[Autoimmune thrombocytopenic purpura (ITP)]] |
| − | |[[Castleman’s disease]] | + | |style="background-color:#98FB98"|[[Castleman’s disease]] |
| − | |[[Coagulopathies]] | + | |style="background-color:#98FB98"|[[Coagulopathies]] |
|- | |- | ||
| − | |[[Hemophagocytic lymphohistiocytosis (HLH)]] | + | |style="background-color:#98FB98"|[[Hemophagocytic lymphohistiocytosis (HLH)]] |
| − | |[[Histiocytoses]] | + | |style="background-color:#98FB98"|[[Histiocytoses]] |
| − | |[[Paroxysmal nocturnal hemoglobinuria (PNH)]] | + | |style="background-color:#98FB98"|[[Paroxysmal nocturnal hemoglobinuria (PNH)]] |
| − | |[[Venous thromboembolism (VTE)]] | + | |style="background-color:#98FB98"|[[Venous thromboembolism (VTE)]] |
|- | |- | ||
|} | |} | ||
Revision as of 01:49, 27 February 2015
HemOnc.org - A Free Hematology/Oncology Reference
4,428 regimens on HemOnc.org |
6,544 variants on HemOnc.org
|
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.
Browse our complete index of pages
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:
- Creating a database of chemotherapy agents and other medications.
- Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Establishing homepages for ongoing clinical trials that contain information and sites of participation
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.
If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.